 |
New study indicates that even delayed treatment with oseltamivir improves survival in patients infected with avian influenza (H5N1)A study published in the Journal of Infectious Diseases indicates that treatment with oseltamivir significantly reduces mortality in patients with influenza A/H5N1, or ‘bird flu’, even when given late in the course of illness. Read the full release. Click on one of the links below to watch an interview with Dr. Nancy Dreyer discussing the study: Tell us about the study: Any learning from the H1N1 pandemic? How can avian influenza be treated? How serious is H5N1 avian influenza? Is avian influenza still a significant threat? What do you see as the main barriers to treatment? What size was the study population? Who is affected by avian influenza?
For further information please contact: Nancy Dreyer, MPH, PhD, Chief of Scientific Affairs and Senior Vice President, Outcome +1 (617) 715-6810 |